Les publications HAL NUMECAN

2012

115 publication(s):

Articles

: 61 -
: Impact of a mutator phenotype on motility and cell adherence in Salmonella Heidelberg.
: Hervé Le Bars, Sandrine Le Gall-David, Virginie Madeleine Renoux, Martine Bonnaure-Mallet, Anne Jolivet-Gougeon, Latifa Bousarghin
: Impact of a mutator phenotype on motility and cell adherence in Salmonella Heidelberg. Veterinary Microbiology, 2012, 159 (1-2), pp.99-106.
: DOI : https://doi.org/10.1016/j.vetmic.2012.03.025
: Pubmed : 22483239

: 62 -
: A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse.
: Caroline Le Lan, Anne Guillygomarc'H, Hélène Danielou, Gérard Le Dréau, Fabrice Lainé, Claude Védeilhié, Yves Deugnier, Pierre Brissot, Dominique Guyader, Romain Moirand
: A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse. Journal of Hepatology, 2012, 56 (2), pp.334-40.
: DOI : https://doi.org/10.1016/j.jhep.2011.05.021
: Pubmed : 21756854

: 63 -
: Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization.
: Laurence Lenoir, Julien Edeline, Yan Rolland, Marc Pracht, Jean-Luc Raoul, Valérie Ardisson, Patrick Bourguet, Bruno Clément, Eveline Boucher, Etienne Garin
: Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization. European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 (5), pp.872-80.
: DOI : https://doi.org/10.1007/s00259-011-2033-4
: Pubmed : 22237844

: 64 -
: Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.
: Nicolas Lepareur, Sophie Laffont, Valérie Ardisson, Nicolas Noiret, Etienne Garin
: Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment. Nuclear Medicine Communications, 2012, 33 (2), pp.205-8.
: DOI : https://doi.org/10.1097/MNM.0b013e32834e7580
: Pubmed : 22124362

: 65 -
: (188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside.
: Nicolas Lepareur, Valérie Ardisson, Nicolas Noiret, Etienne Garin
: (188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside. International Journal of Molecular Imaging, 2012, 2012, 278306 (9 p.).
: DOI : https://doi.org/10.1155/2012/278306
: Pubmed : 22518301

: 66 -
: Regulation of the hepatocyte cell cycle: signaling pathways and protein kinases.
: Pascal Loyer, Anne Corlu, Chantal Desdouets
: Regulation of the hepatocyte cell cycle: signaling pathways and protein kinases. International Journal of Hepatology, 2012, 2012, pp.592354.
: DOI : https://doi.org/10.1155/2012/592354
: Pubmed : 23320182

: 67 -
: Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines.
: Bénédicte Martin, Julien Edeline, Jean-Jacques Patard, Emmanuel Oger, Florence Jouan, Gaëlla Boulanger, Sélim Zerrouki, Cécile Vigneau, Nathalie Rioux-Leclercq
: Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines. Journal of Cancer Research and Clinical Oncology, 2012, 138 (6), pp.907-916.
: DOI : https://doi.org/10.1007/s00432-012-1162-x
: Pubmed : 22322364

: 68 -
: Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
: Julie Massart, Marie-Anne Robin, Fanny Noury, Alain Fautrel, P. Lettéron, A. Bado, Pierre-Antoine Eliat, Bernard Fromenty
: Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis. British Journal of Pharmacology, 2012, 165 (5), pp.1361-74.
: DOI : https://doi.org/10.1111/j.1476-5381.2011.01580.x
: Pubmed : 21740407

: 69 -
: Dental abnormalities in Schimke immuno-osseous dysplasia.
: M. Morimoto, O. Kérourédan, M. Gendronneau, C. Shuen, A. Baradaran-Heravi, Y. Asakura, M. Basiratnia, R. Bogdanovic, D. Bonneau, A. Buck, J. Charrow, P. Cochat, K. A. Dehaai, M. S. Fenkçi, P. Frange, S. Fründ, H. Fryssira, K. Keller, S. Kirmani, C. Kobelka, K. Kohler, D. B. Lewis, L. Massella, D. R. Mcleod, D. V. Milford, F. Nobili, A. H. Olney, C. N. Semerci, N. Stajic, A. Stein, Sophie Taque, J. Zonana, T. Lücke, G. Hendson, Martine Bonnaure-Mallet, C. F. Boerkoel
: Dental abnormalities in Schimke immuno-osseous dysplasia. Journal of Dental Research, 2012, 91 (7 Suppl), pp.29S-37S.
: DOI : https://doi.org/10.1177/0022034512450299
: Pubmed : 22699664

: 70 -
: Glycosiderophores: Synthesis of tris-hydroxamate siderophores based on a galactose or glycero central scaffold, Fe(III) complexation studies.
: Christelle Neff, François Bellot, Jenny-Birgitta Waern, F. Lambert, Jérémy Brandel, Guy Serratrice, François Gaboriau, Clotilde Policar
: Glycosiderophores: Synthesis of tris-hydroxamate siderophores based on a galactose or glycero central scaffold, Fe(III) complexation studies. Journal of Inorganic Biochemistry, 2012, 112C, pp.59-67.
: DOI : https://doi.org/10.1016/j.jinorgbio.2012.02.030
: Pubmed : 22551986